Nanomosaic launches AAV gene therapy application products

“We are genomicizing proteomics”

JOHN BOYCE, CO-FOUNDER AND MANAGING DIRECTOR OF TIGERGENE VENTURES. CO-FOUNDER OF NANOMOSAIC

Nano-scale molecular profiling, screening & discovery

Interrogate and understand protein, nucleic acid & other interactions at a nano scale. All in a workflow that’s easy and familiar.

The power of NanoNeedles

Truly multi-omic

Analyze proteins, nucleic acids and more with nano-scale needles.

Work from crude samples

With tens of thousands of binding points, NanoNeedles offer the possibility to work straight from crude samples.

Label-free detection

Our proprietary Nano amplifiers bind to detection antibodies which in turn bind to proteins or nucleic acids in your sample. The amplifiers change nano needles which in turn changes the light refraction.

High-throughput

With protocols running at 96-well or 384-well plates, a typical 2-3 hour workflow and a 10-minute read, run 1000s of samples per day on a single instrument.

Unambiguous data

No peak analyses pipelines, no complex data analysis. The property of light scattering is a direct function of the quantity of analytes.

Applications

Learn what scientists are doing with NanoMosaic

Gene therapies

QC AAV gene therapy capsids & transgenes on one platform

For companies building on AAV vectors, our assays  titer capsids, their payload and the integrity of the payload (full/ empty/ partial/ deletions).
Learn more
Neurology

Blood pTau detection for Alzheimer's disease and related dementia

Use the sensitivity of NanoNeedles to detect important Alzheimer biomarkers from non-invasive samples.
Coming soon

Get in touch with our team for more information

Learn more about NanoMosaic’s platform.